期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
掌腱膜挛缩症的临床回顾性研究 被引量:9
1
作者 李秀存 路来金 +4 位作者 崔建礼 孙希光 刘红霞 张颖 王维 《中华手外科杂志》 CSCD 北大核心 2015年第1期31-33,共3页
目的 探讨掌腱膜挛缩症的治疗体会.方法 对我院2004年10月至2013年12月收治的78例掌腱膜挛缩症患者的发病特点、手术方法、术后并发症及远期疗效进行回顾性分析.结果 本组患者111只手,99只手Ⅰ期愈合,12只手术后出现不同程度的早期并发... 目的 探讨掌腱膜挛缩症的治疗体会.方法 对我院2004年10月至2013年12月收治的78例掌腱膜挛缩症患者的发病特点、手术方法、术后并发症及远期疗效进行回顾性分析.结果 本组患者111只手,99只手Ⅰ期愈合,12只手术后出现不同程度的早期并发症,发生率10.81%.其中68例患者98只手术后平均随访3.9年,6只手复发,术后复发率为6.12%.依据中华医学会手外科学会上肢部分功能评定试用标准评定:优81只手,良11只手,差6只手;优良率为93.88%.结论 早期手术、精细操作将极大降低掌腱膜挛缩症术后出现早期及远期并发症的机会. 展开更多
关键词 回顾性研究 外科手术 掌腱膜挛缩症
原文传递
Dupuytren’s disease:A review
2
作者 Malay Sarkar Nitin Kashyap Irappa Madabhavi 《Chinese Journal of Plastic and Reconstructive Surgery》 2024年第3期142-148,共7页
Dupuytren’s disease is a well-known benign fibroproliferative disorder that affects the palmar and digital fasciae of the hands.This spectrum includes nodule formation,cord formation,and flexion contracture of the di... Dupuytren’s disease is a well-known benign fibroproliferative disorder that affects the palmar and digital fasciae of the hands.This spectrum includes nodule formation,cord formation,and flexion contracture of the digits,which may result in functional limitations.These deformities are often progressive and irreversible.Surgery is a cornerstone therapy.This review discusses the epidemiology,pathophysiology,risk factors,clinical manifestations,and management of Dupuytren’s disease. 展开更多
关键词 dupuytren’s contracture dupuytren’s disease Palmar aponeurosis FASCIECTOMY
下载PDF
Long-term assessment of collagenase treatment for Dupuytren’s contracture:A 10-year follow-up study
3
作者 Marco Passiatore Vitale Cilli +4 位作者 Adriano Cannella Ludovico Caruso Giulia Maria Sassara Giuseppe Taccardo Rocco De Vitis 《World Journal of Orthopedics》 2024年第4期355-362,共8页
BACKGROUND Enzymatic fasciotomy with collagenase clostridium histolyticum(CCH)has revolutionized the treatment for Dupuytren’s contracture(DC).Despite its benefits,the long-term outcomes remain unclear.This study pre... BACKGROUND Enzymatic fasciotomy with collagenase clostridium histolyticum(CCH)has revolutionized the treatment for Dupuytren’s contracture(DC).Despite its benefits,the long-term outcomes remain unclear.This study presented a comprehensive 10-year follow-up assessment of the enduring effects of CCH on patients with DC.AIM To compare the short-term(12 wk)and long-term(10 years)outcomes on CCH treatment in patients with DC.METHODS A cohort of 45 patients was treated with CCH at the metacarpophalangeal(MCP)joint and the proximal interphalangeal(PIP)joint and underwent systematic reevaluation.The study adhered to multicenter trial protocols,and assessments were conducted at 12 wk,7 years,and 10 years post-surgery.RESULTS Thirty-seven patients completed the 10-year follow-up.At 10 years,patients treated at the PIP joint exhibited a 100%recurrence.However,patients treated at the MCP joint only showed a 50%recurrence.Patient satisfaction varied,with a lower satisfaction reported in PIP joint cases.Recurrence exceeding 20 degrees on the total passive extension deficit was observed,indicating a challenge for sustained efficacy.Significant differences were noted between outcomes at the 7-year and 10-year intervals.CONCLUSION CCH demonstrated sustained efficacy when applied to the MCP joint.However,caution is warranted for CCH treatment at the PIP joint due to a high level of recurrence and low patient satisfaction.Re-intervention is needed within a decade of treatment. 展开更多
关键词 COLLAGENASE Xiapex dupuytren disease dupuytren recurrence Long term follow-up
下载PDF
改良Skoog法治疗Ⅲ期掌腱膜挛缩症的疗效分析 被引量:2
4
作者 马月 贾乐 +3 位作者 王冠 许玉林 鲁晓波 葛建华 《四川医学》 CAS 2022年第6期573-577,共5页
目的回顾改良Skoog法治疗掌腱膜挛缩症病例,观察和分析其临床疗效。方法选择2012年1月至2020年1月我院骨科两个病区共收治Meyerding分期为Ⅲ期掌腱膜挛缩症患者14例(19肢),病程12~42个月,平均(27.38±9.13)个月,男12例,女2例,年龄42... 目的回顾改良Skoog法治疗掌腱膜挛缩症病例,观察和分析其临床疗效。方法选择2012年1月至2020年1月我院骨科两个病区共收治Meyerding分期为Ⅲ期掌腱膜挛缩症患者14例(19肢),病程12~42个月,平均(27.38±9.13)个月,男12例,女2例,年龄42~79岁,平均(66.38±9.53)岁。所有患者均采用改良Skoog法行掌腱膜全切,术后观察切口愈合、手功能康复以及并发症发生等情况。采用中华医学会手功能评定试用标准和1975年美国手外科学会推荐的TAM系统评定方法评定手功能与手指活动度。结果所有患者随访12~48个月,平均(30.00±9.87)个月。10例患者切口Ⅰ期愈合;2例切口延迟愈合,1例切口缘部分皮肤坏死,积极换药处理后愈合;1例术后伴环指、小指感觉异常,所有患者随访期内未见复发。评定结果:优10例,良3例,中1例。末次随访时,手功能与手指的活动范围较术前明显纠正,差异有统计学意义(P<0.05)。结论运用改良Skoog法行掌腱膜全切治疗Ⅲ期掌腱膜挛缩,效果确切,术后切口愈合及功能恢复满意,值得临床应用推广。 展开更多
关键词 掌腱膜挛缩症 手术切除 Skoog法
下载PDF
Systematic review of the non surgical management of Peyronie's disease
5
作者 Paolo Verze Davide Arcaniolo +6 位作者 Tommaso Cai Marco Franco Roberto La Rocca Mario Acquaviva Lorenzo Spirito Aleksandre Bochorishvili Vincenzo Mirone 《World Journal of Clinical Urology》 2014年第1期31-37,共7页
This systematic review shows the "Status quo" on medical treatment for Peyronie's disease(PD). PD is a connective tissue disorder, characterised by the formation of a fibrotic lesion or plaque in the tun... This systematic review shows the "Status quo" on medical treatment for Peyronie's disease(PD). PD is a connective tissue disorder, characterised by the formation of a fibrotic lesion or plaque in the tunica albuginea, which leads to penile deformity. The aetiology of PD is unknown. Nowadays the most widely accepted hypothesis proposed by Gonzalez-Cadavid et al, is repetitive microvascular injury or trauma to the tunica albuginea. Physicians have proposed several medical alternatives for treatment of this disease with few effective results. Nevertheless, as of today nonsurgical options are currently available, and some of them are able to stabilize or even reduce deformity while improving pain relief and sexual function. A systematic literature search throughout the Medline database was carried out. Thecontrolled vocabulary of the medical subject headings database employs the specific term "penile induratio" for PD. A total of 50 articles on PD were found. Studies were selected based on clinical relevance. The recommended standard of care for PD involves an initial treatment in the acute phase. Several non-operative treatment options have been used. Unfortunately no further substantial, quality evidence on the use of medical therapy currently exits. There is, however, an increasingly enhanced interest in this disorder and basic scientifi c and clinical research will eventually lead to a more effective methodology to study the disease. 展开更多
关键词 Peyronie’s disease Non SURGICAL dupuytren EXTRACORPOREAL SHOCKWAVE THERAPY
下载PDF
Downregulation of Scar Fibroblasts by Antineoplastic Drugs: A Potential Treatment for Fibroproliferative Disorders
6
作者 M. Georgina Uberti Yvonne N. Pierpont +3 位作者 Rajat Bhalla Karan Desai Martin C. Robson Wyatt G. Payne 《Surgical Science》 2016年第6期258-271,共14页
The various fibroproliferative disorders affecting humans have in common excess fibroblast activity and persistent overexpression or dysregulated activity of transforming growth factor beta (TGF-β). Cancer has many s... The various fibroproliferative disorders affecting humans have in common excess fibroblast activity and persistent overexpression or dysregulated activity of transforming growth factor beta (TGF-β). Cancer has many similar characteristics. Antineoplastic drugs can downregulate fibroblast activity and cytokine growth factors. This study evaluates the effect of six antineoplastic drugs on keloid and Dupuytren’s disease fibroblasts. Keloid, normal scar, Dupuytren’s affected palmar fascia, and normal palmar fascia fibroblasts were grown and seeded into Fibroblast Populated Collagen Lattices (FPCLs). The FPCLs were treated with one of six antineoplastic drugs or left untreated as controls. At 7 days, supernatants were extracted from all FPCLs and assayed for expression of Transforming Growth Factor beta (TGF)-β<sub>1</sub> and TGF-β<sub>2</sub>. All six antineoplastic drugs significantly inhibited FPCL contraction in both fibroproliferative conditions compared with the untreated controls (p β<sub>1</sub> and TGF-β<sub>2</sub> expression was downregulated in the supernatants of all FPCLs by the drug exposure. Cytotoxicity did not occur in these studies and was not the reason for the results. Although antineoplastic drugs can have significant side effects when given systemically, these results may be minimized when given to small areas involved in fibroproliferative scarring or when given topically or intralesionally. These in vitro results suggest that antineoplastic drugs may have a utility for treating various fibroproliferative disorders and warrant further investigation. 展开更多
关键词 Scar Fibroblasts Antineoplastic Drugs Fibroproliferative Disorders dupuytren’s disease KELOID
下载PDF
掌腱膜挛缩症中手指屈曲畸形治疗的临床研究 被引量:2
7
作者 沈尊理 黄一雄 +4 位作者 郭效朋 邢书亮 张兆峰 沈华 贾万新 《中国美容整形外科杂志》 CAS 2010年第12期725-727,共3页
目的 研究掌腱膜挛缩症中手指屈曲畸形矫治方法 及其疗效.方法 本组患者17例,其中男性15例,女性2例;平均年龄58岁.均有掌腱膜挛缩症,伴小指屈曲挛缩8侧,伴环小指屈曲挛缩8侧,伴中环指屈曲挛缩1侧,伴环指屈曲挛缩2侧,共19侧.沿掌腱膜挛... 目的 研究掌腱膜挛缩症中手指屈曲畸形矫治方法 及其疗效.方法 本组患者17例,其中男性15例,女性2例;平均年龄58岁.均有掌腱膜挛缩症,伴小指屈曲挛缩8侧,伴环小指屈曲挛缩8侧,伴中环指屈曲挛缩1侧,伴环指屈曲挛缩2侧,共19侧.沿掌腱膜挛缩索带纵轴设计锯齿状切口,彻底切除病变的挛缩腱膜组织及其附近5 mm范围的腱膜组织.然后稍加外力松解指关节周围的挛缩组织,使手指恢复伸直位.术后2周给予手指伸直位石膏托制动.结果 所有患者随访6~24个月.锯齿形皮瓣均存活,未见神经肌腱损伤并发症.手掌部皮瓣尖角出现血运障碍2例,经换药后完全愈合.未见手指屈曲挛缩复发,手指屈伸活动度恢复优良率100%.结论 采用锯齿状切口,应注意保护皮瓣血运和指神经血管束,彻底切除松解病变的腱膜组织,可有效矫正掌腱膜挛缩引起的手指屈曲畸形,避免并发症的发生. 展开更多
关键词 掌腱膜挛缩症 手指 屈曲畸形 皮瓣
原文传递
Clinical study of correction of finger flexion deformity in Dupuytren's disease
8
作者 沈尊理 《外科研究与新技术》 2011年第4期270-270,共1页
Objective To explore surgical technique and its result in correcting finger contracture in Dupuytren’s disease. Methods Seventeen cases of Dupuytren’s disease with 58 years mean age were studied in this group ( 15 m... Objective To explore surgical technique and its result in correcting finger contracture in Dupuytren’s disease. Methods Seventeen cases of Dupuytren’s disease with 58 years mean age were studied in this group ( 15 males and 2 females) . Among them,8 sides were with flexion eontracture of little finger,8 sides with flexion contracture of little and ring fingers,1 side with 展开更多
关键词 Clinical study of correction of finger flexion deformity in dupuytren’s disease
下载PDF
Collagenase clostridium histolyticum for Dupuytren disease nodules
9
作者 Costas B Coleman S Kaufman G 《中华物理医学与康复杂志》 CAS CSCD 北大核心 2017年第12期902-902,共1页
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部